Getting a prescription is not always the same as getting access to treatment. For patients prescribed specialty medications or other complex therapies, the path between a healthcare provider’s treatment decision and the start of therapy can include insurance verification, prior authorization, coverage restrictions, documentation requests, appeals, and questions about out-of-pocket costs. These steps can be difficult for patients and time-consuming for healthcare provider offices to manage. Reimbursement specialists help navigate that path, coordinating the administrative work required to understand coverage, address reimbursement barriers, and keep the access process moving.

What Reimbursement Specialists Actually Do

Reimbursement specialists work at the intersection of patients, healthcare providers, payers, pharmacies, and patient support programs. Their role is not to make clinical decisions or determine whether an insurer should cover a therapy. Instead, they help understand and navigate the coverage requirements surrounding a prescribed treatment.

That work commonly begins with a benefits investigation. The goal is to establish how a patient’s insurance applies to the prescribed therapy and identify potential obstacles before they become larger delays. Depending on the therapy and benefit structure, this may involve determining whether prior authorization is required, identifying coverage restrictions, clarifying patient cost-sharing responsibilities, and understanding what information a payer needs before making a coverage decision. Published research on specialty medication access programs describes dedicated access personnel performing benefits investigations, obtaining prior authorizations, and helping connect eligible patients with financial assistance resources.

From there, reimbursement specialists may coordinate with provider offices to obtain missing information, monitor an authorization request, document payer communications, and help identify the appropriate next step when a request is denied or additional documentation is required. Coverage determinations as encompassing issues such as formulary exceptions, cost-sharing disputes, quantity restrictions, step therapy, and whether prior authorization requirements have been satisfied.

The work can be detailed, but the objective is straightforward: prevent an administrative barrier from becoming an unnecessary barrier to treatment.

Why Prior Authorization Makes Reimbursement Expertise Important

Prior authorization is intended to establish that certain treatments meet a health plan’s coverage requirements before the plan will pay for them. In practice, however, managing those requirements can demand significant time and repeated communication.

The scale of that workload is substantial. In the American Medical Association’s 2026 physician survey, physicians reported completing an average of 40 prior authorizations each week, consuming approximately 13 hours of physician and staff time. Forty percent said they employ staff dedicated exclusively to prior authorization. The same survey found that 95% of physicians reported prior authorization delays access to necessary care, while 79% reported patients abandoning treatment because of authorization challenges.

Those numbers help explain why specialized reimbursement support matters. A missing clinical document, an overlooked payer requirement, or an unresolved denial can add another step to an already complicated process.

Denials also are not necessarily the end of the access journey. An HHS Office of Inspector General review of Medicare Advantage prior authorization denials found that 13% of the denied requests it reviewed met Medicare coverage rules. The report identified issues including additional clinical criteria, documentation disputes, and administrative errors, and noted that some denials were later reversed.

A reimbursement specialist can help ensure that a case does not simply stop when a problem appears. Instead, the issue can be identified, documented, and routed appropriately for follow-up.

Coverage Is Only One Part of Patient Access

Even after coverage is established, affordability can still stand between a patient and treatment.

This is particularly relevant for specialty therapies. A 2023 systematic review of 44 studies examining specialty drug utilization found that higher patient cost sharing was associated with lower treatment initiation and persistence. In studies included in the review, cost sharing above $100 was associated with specialty drug abandonment rates as high as 75% for certain therapies. Conversely, programs that reduced patient cost sharing were associated with greater treatment initiation and persistence.

For reimbursement specialists, understanding the patient’s coverage picture therefore means looking beyond a simple approved-or-denied status. An authorization may be approved while the patient still faces a significant financial barrier.

Where appropriate and permitted by program rules, reimbursement specialists and other access professionals may help identify available financial assistance pathways and explain the administrative requirements associated with them. Research from an academic oncology specialty pharmacy, for example, describes medication access coordinators handling benefits investigations, prior authorizations, and enrollment into financial assistance programs. In that program, financial interventions helped patients access copay support, charitable grants, and manufacturer assistance programs.

The specialist’s value is not in promising that assistance will always be available. It is in helping determine what options exist and what steps are necessary to pursue them.

Technology Is Changing the Workflow, Not Eliminating the Need for Expertise

Reimbursement workflows are becoming increasingly digital. Electronic prior authorization, real-time benefit information, payer portals, and automated workflow tools can reduce repetitive tasks and make information easier to exchange.

Federal policy is moving in the same direction. Under CMS’s 2024 Interoperability and Prior Authorization Final Rule, certain impacted payers must meet new decision timeframes for prior authorization of non-drug items and services and provide specific reasons for denials. CMS is also requiring electronic prior authorization capabilities beginning in 2027 for those covered items and services.

Drug authorization is continuing to evolve as well. In April 2026, CMS proposed expanding electronic prior authorization requirements to drugs under certain federal healthcare programs, including proposals for more standardized electronic information exchange and greater transparency around authorization decisions. As of August 2026, those drug provisions remain proposed, rather than final.

Better technology can make reimbursement work faster and more organized, but it does not make every case identical. Coverage varies among plans, therapies, benefit types, and individual circumstances. A system can flag that information is missing. An experienced specialist still needs to understand what the information means, communicate with the appropriate stakeholders, and determine how to move the case forward.

Keeping the Patient at the Center of Reimbursement

To patients, reimbursement terminology can sound distant from healthcare. Benefits investigations, prior authorizations, formulary restrictions, appeals, and payer requirements are administrative concepts. Their consequences are not.

When those processes stall, a patient may be waiting to start a therapy their healthcare provider has already recommended. The purpose of reimbursement specialists is to bring focus and continuity to the administrative side of that journey, helping provider offices understand requirements, following cases through the coverage process, and identifying access barriers before they are forgotten or allowed to linger.

That makes reimbursement specialists more than paperwork processors. They are part of the infrastructure that connects a treatment decision with the practical realities of obtaining that treatment.

Serva Health’s previous article, “Reimbursement Struggles are Real,” explores the broader effect reimbursement barriers can have on patients and care teams, including the often-unseen work occurring behind every authorization and appeal.

As healthcare reimbursement becomes more complex and more digital at the same time, specialized expertise remains important. Technology can improve the process, but reimbursement specialists provide something equally necessary: attention to the individual case and the persistence required to help keep the path to treatment moving.